Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established Biomarkers

α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response

(2016) Yoshihiko Tachi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness

(2016) Cristina Stasi   WORLD JOURNAL OF GASTROENTEROLOGY

Identification of novel noninvasive markers for diagnosing nonalcoholic steatohepatitis and related fibrosis by data mining

(2015) Keito Yoshimura et al.   HEPATOLOGY

The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease

(2015) Katharine M. Irvine et al.   LIVER INTERNATIONAL

ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity

(2015) Kevin J. Fagan et al.   LIVER INTERNATIONAL

Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias

(2015) António Morais et al.   RESPIRATORY MEDICINE

Metabolic Phenotyping for Enhanced Mechanistic Stratification of Chronic Hepatitis C-Induced Liver Fibrosis

(2014) Caroline J Sands et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B

(2014) Yu-rui Liu et al.   BMC GASTROENTEROLOGY

The role of neutrophils in the development of liver diseases

(2014) Ruonan Xu et al.   Cellular & Molecular Immunology

Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure

(2014) Keisuke Kakisaka et al.   HEPATOLOGY RESEARCH

The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis

(2014) Qingsong Xie et al.   PLoS One

Evaluation of the Aspartate Aminotransferase/Platelet Ratio Index and Enhanced Liver Fibrosis Tests to Detect Significant Fibrosis Due to Chronic Hepatitis C

(2013) John R. Petersen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models

(2013) Mohamed A. Chinnaratha et al.   LIVER INTERNATIONAL

DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway

(2013) Liang Chen et al.   Molecular Cancer

Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis

(2012) Thierry Poynard et al.   Clinical Gastroenterology and Hepatology

Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

(2012) Aloysious Aravinthan et al.   JOURNAL OF HEPATOLOGY

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease

(2011) Leon A Adams et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis

(2010) Mireen Friedrich-Rust et al.   BMC GASTROENTEROLOGY

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C

(2010) J. Parkes et al.   JOURNAL OF VIRAL HEPATITIS

Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy

(2009) Kawin Leelawat et al.   BMC GASTROENTEROLOGY

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

(2008) Philippe Halfon et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Exceeding the limits of liver histology markers

(2008) Shruti H. Mehta et al.   JOURNAL OF HEPATOLOGY